1. Zhang, Qinzhen, Xia, Tianxiang, Qi, Chenxiang, Du, Jun, Ye, Chunping. 2022. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. In BMC cancer, 22, 77. doi:10.1186/s12885-022-09180-5. https://pubmed.ncbi.nlm.nih.gov/35042454/
2. Lapi, E, Iovino, A, Fontemaggi, G, Blandino, G, Strano, S. 2006. S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. In Oncogene, 25, 3628-37. doi:. https://pubmed.ncbi.nlm.nih.gov/16449968/
3. Buckley, N E, D'Costa, Z, Kaminska, M, Mullan, P B. 2014. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. In Cell death & disease, 5, e1070. doi:10.1038/cddis.2014.31. https://pubmed.ncbi.nlm.nih.gov/24556685/
4. Zhao, Xin, Li, Han, Lyu, Shaocheng, Lang, Ren, He, Qiang. 2021. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. In International journal of biological sciences, 17, 2590-2605. doi:10.7150/ijbs.58886. https://pubmed.ncbi.nlm.nih.gov/34326696/
5. Nagy, N, Brenner, C, Markadieu, N, Kiss, R, Decaestecker, C. . S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. In Laboratory investigation; a journal of technical methods and pathology, 81, 599-612. doi:. https://pubmed.ncbi.nlm.nih.gov/11304580/
6. Zhang, Yu, Yang, Xin, Zhu, Xiao-Lin, Hao, Chun-Yan, Duan, Hu-Bin. 2021. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma. In Aging, 13, 15459-15478. doi:10.18632/aging.203103. https://pubmed.ncbi.nlm.nih.gov/34148033/
智鼠故事 
